Sotera Health (SHC) EBITDA (2020 - 2026)

Sotera Health (SHC) has reported EBITDA for 7 consecutive years, with $10.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBITDA rose 89.36% year-over-year to $10.5 million; the TTM figure through Mar 2026 stood at $181.3 million (up 504.87% YoY), while the FY2025 annual figure was $176.4 million, up 347.8% from the prior year.
• EBITDA came in at $10.5 million for Q1 2026 at Sotera Health, down from $50.5 million in the prior quarter.
• The five-year high for EBITDA was $89.1 million in Q2 2025, with the low at -$262.4 million in Q4 2022.
• Average EBITDA over 5 years is -$4.4 million, with a median of $5.5 million recorded in 2025.
• Across the five-year window, EBITDA sank 3159.33% in 2022 and surged 630.93% in 2025, its largest moves.
• Year by year, EBITDA stood at -$262.4 million in 2022, then soared by 122.92% to $60.1 million in 2023, then tumbled by 218.57% to -$71.3 million in 2024, then soared by 170.84% to $50.5 million in 2025, then slumped by 79.24% to $10.5 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $10.5 million, $50.5 million, and $31.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.